What is the future for drug development in atherosclerosis and dyslipidaemia?

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.4, Iss.1, 2009-01, pp. : 1-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current, New and Future Treatments in Dyslipidaemia and Atherosclerosis

By Chong P.H.

Drugs, Vol. 60, Iss. 1, 2000-07 ,pp. : 55-93

Adis International

Access to resources Recommend Favorite

The landscape of drug discovery in atherosclerosis and dyslipidaemia revisited: an update of patenting activity

By Suckling Keith

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 3, 2012-03 ,pp. : 199-204

Informa Healthcare

Access to resources Recommend Favorite

The landscape of drug discovery in atherosclerosis and dyslipidaemia: a survey from patenting activity

By Suckling Keith

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 5, 2008-05 ,pp. : 473-484

Informa Healthcare

Access to resources Recommend Favorite

Atherosclerosis imaging in drug development

By Nicholls Stephen J Kalidindi Srinivasa Moon Keon-Woong Nissen Steven E

Expert Opinion on Drug Discovery, Vol. 2, Iss. 9, 2007-09 ,pp. : 1241-1250

Informa Healthcare

Access to resources Recommend Favorite

Liposomal Drug Formulations: Rationale for Development and What We Can Expect for the Future

By Allen T.M.

Drugs, Vol. 56, Iss. 5, 1998-11 ,pp. : 747-756

Adis International

Access to resources Recommend Favorite